Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles.
In passing, it is worth mentioning that the oncologist who gave al
Megrahi a few months to live was not a prostate cancer expert, and it
seems clear that bestowing a very short survival time on him was
At that time, during a meeting of prostate cancer oncologists, there
was lots of informal discussion about what the true prognosis was likely
to be. It seemed probable that al Megrahi had been diagnosed with hormone
resistant disease but had not yet received any treatment such as
chemotherapy. There was consensus that, in such cases, the prognosis was
invariably 'about 2 years', which takes us up to.....well, now, actually.